Report cover image

Veterinary Therapeutics Market by Product (Drug Type, Medicated Feed Additive, Vaccines Type), Animal (Companion Animal, Livestock Animal), Route of Administration, End User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 191 Pages
SKU # IRE18451494

Description

Veterinary Therapeutics Market by Product (Drug Type, Medicated Feed Additive, Vaccines Type), Animal (Companion Animal, Livestock Animal), Route of Administration, End User - Global Forecast 2024-2030


The Veterinary Therapeutics Market size was estimated at USD 38.05 billion in 2023 and expected to reach USD 40.77 billion in 2024, at a CAGR 7.23% to reach USD 62.04 billion by 2030.

Global Veterinary Therapeutics Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Biogénesis Bagó SA, Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma Unlimited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories Inc., ImmuCell Corporation, Indian Immunologicals Ltd., Merck & Co. Inc., Neogen Corporation, Novartis International AG, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol Group, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Drug Type
Anti-Inflammatory

Anti-Invectives

Parasiticides
Medicated Feed Additive
Amino Acids

Antibiotics

Online Pharmacy

Retail Pharmacy
Vaccines Type
Attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines
Animal
Companion Animal
Livestock Animal
Route of Administration
Oral
Parenteral
Topical
End User
Pharmacies & Drug Store
Veterinary Clinic
Veterinary Hospital
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Veterinary Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Veterinary Therapeutics Market?
4. What is the market share of the leading vendors in the Veterinary Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Veterinary Therapeutics Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

191 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Veterinary Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of companion animal and livestock ownership
5.1.1.2. Improving veterinary care facilities in economies
5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
5.1.2. Restraints
5.1.2.1. High cost of veterinary therapeutics
5.1.3. Opportunities
5.1.3.1. Growing new product approvals in economies
5.1.3.2. Increasing R&D activities to develop new therapeutics
5.1.4. Challenges
5.1.4.1. Issues with quality management
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Veterinary Therapeutics Market, by Product
6.1. Introduction
6.2. Drug Type
6.3.1. Anti-Inflammatory
6.3.2. Anti-Invectives
6.3.3. Parasiticides
6.3. Medicated Feed Additive
6.4.1. Amino Acids
6.4.2. Antibiotics
6.4.3. Online Pharmacy
6.4.4. Retail Pharmacy
6.4. Vaccines Type
6.5.1. Attenuated Vaccines
6.5.2. Inactivated Vaccines
6.5.3. Recombinant Vaccines
7. Veterinary Therapeutics Market, by Animal
7.1. Introduction
7.2. Companion Animal
7.3. Livestock Animal
8. Veterinary Therapeutics Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Topical
9. Veterinary Therapeutics Market, by End User
9.1. Introduction
9.2. Pharmacies & Drug Store
9.3. Veterinary Clinic
9.4. Veterinary Hospital
10. Americas Veterinary Therapeutics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Veterinary Therapeutics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Veterinary Therapeutics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Biogénesis Bagó SA
14.1.2. Biovac Ltd.
14.1.3. Boehringer Ingelheim International GmbH
14.1.4. Ceva Santé Animale
14.1.5. Chanelle Pharma Unlimited
14.1.6. Dechra Pharmaceuticals PLC
14.1.7. Elanco Animal Health Incorporated
14.1.8. Eli Lilly and Company
14.1.9. Heska Corporation
14.1.10. Hester Biosciences Limited
14.1.11. IDEXX Laboratories Inc.
14.1.12. ImmuCell Corporation
14.1.13. Indian Immunologicals Ltd.
14.1.14. Merck & Co. Inc.
14.1.15. Neogen Corporation
14.1.16. Novartis International AG
14.1.17. Nutreco N.V.
14.1.18. Phibro Animal Health Corporation
14.1.19. Vetoquinol Group
14.1.20. Zoetis, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. VETERINARY THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VETERINARY THERAPEUTICS MARKET DYNAMICS
FIGURE 7. VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
FIGURE 10. VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us